"Die nordBLICK Augenklinik Bellevue ist in Norddeutschland eine der renommiertesten Kliniken für refraktive Chirurgie. Vier hochmodern eingerichtete OP-Säle, ein Eingriffsraum, ein Laserzentrum und modernste Geräte – für Ihre Gesundheit und Ihr Wohlbefinden. Unser Ärzteteam hat bereits über 200.000 Operationen durchgeführt und zählt zu den besten Chirurgen Deutschlands. Unser Leistungsspektrum : • Laserverfahren (Femto-Lasik & Trans-PRK) • Linsenverfahren (Evo Visian ICL & Refraktiver Linsentausch RLA) In einem kostenlosen und unverbindlichen Beratungstermin inkl. Eignungscheck wird von unseren Experten geprüft, welches Behandlungsverfahren für Ihre individuellen Bedürfnisse in Frage kommen würde. Wir freuen uns auf Sie!"

During the past decade, nordBLICK Augenklinik Bellevue conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "nordBLICK Augenklinik Bellevue" #1 collaborator was "Syneos Health" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "nordBLICK Augenklinik Bellevue" are "Neovascular Age-related Macular Degeneration" (1 trials), "Neurotrophic Keratitis" (1 trials) and "Primary Open Angle Glaucoma (POAG)" (1 trials). Many other conditions were trialed in "nordBLICK Augenklinik Bellevue" in a lesser frequency.

Most popular intervention types in "nordBLICK Augenklinik Bellevue" are "Drug" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AKST4290" (1 trials), "ARGOS-IO system" (1 trials), "Aflibercept" (1 trials), "Placebo" (1 trials) and "Udonitrectag" (1 trials). Other intervention names were less common.

The vast majority of trials in "nordBLICK Augenklinik Bellevue" are 3 trials for "All" genders.

Currently, there are NaN active trials in "nordBLICK Augenklinik Bellevue". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in nordBLICK Augenklinik Bellevue, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in nordBLICK Augenklinik Bellevue, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".